Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Arrow Electronics, Inc.’s ( ARW - Analyst Report ) operating unit Arrow Enterprise Computing Solutions (ECS) recently signed a distribution agreement with Emerson Network Power. This will introduce Emerson’s wide range of enterprise data center infrastructure management (DCIM) services to Arrow’s distribution channel database catering to the needs of its comprehensive clientele in the United States.
The venture undertaken is to directly distribute Emerson’s real-time infrastructure optimization Trellis portal in order to improve the efficacy of the data center. Moreover, the company will be also managing and supporting data center’s IT and facilities systems through supplying a wide range of DCIM solution including Avocent Universal Management Gateway, Avocent DSView, MergePoint Unity, ACS and PM3000 solutions. By adding these solutions to its line card offerings in the United States, Arrow will make the entire infrastructure management of the data centers less costly and more efficient for its customers.
Management was appeased regarding its decision to conflate with Emerson, as this venture would allow Arrow to provide best-in-class data center management through integrating with Emerson’s DCIM solution. These solutions would easily cater to the needs of Arrow’s data center customers.
Recently the company reported revenues of $1.59 billion, up 3.0% year over year in its Global enterprise computing solutions (ECS) segment. The rise in the sales was on the back of the Americas’ solid performance in the core value-added distribution business and Europe’s strong performance even amid the weak market conditions due to the company’s matrix expansion. We believe that this agreement would further bolster the performance of this segment moving ahead.
However, it should be noted that the company’s domestic and foreign operations are subject to significant competitive pressures from the likes of Richardson Electronics Ltd. ( RELL - Snapshot Report ) and Avnet, Inc. ( AVT - Analyst Report ) . Avnet very recently acquired Genilogix LLC for strengthening its HP software solutions and Cloud services. Hence, to compete successfully, Arrow must excel in terms of product quality and innovation, customer service, technical and computing capabilities and price competitiveness.
The current Zacks Consensus Estimates for Arrow are $1.09 and $4.27 for the fourth quarter of 2012 and for 2012, respectively. The estimates represent a year-over-year growth of (21.34%) for the fourth quarter and (17.78%) for 2012. The company currently retains a Zacks #5 Rank, which translates into a short-term ‘Strong Sell’ rating. We also maintain a long-term ‘Neutral’ recommendation on the stock.
Read the full Analyst Report on ARW
Read the full Analyst Report on AVT
Read the full Snapshot Report on RELL